It was found that the CD8+T_CCL4L2 subpopulation more significantly varied in the tissues of HT patients, and the NKT_KLRD1_KLRC2 subpopulation exhibited a significant variation in the PBMCs of HT patients (Figure 3C). The gene discussed is CCL4L2; the disease is hematocrit.